Core Insights - Avient reported revenue of $826.6 million for the quarter ended March 2025, a decrease of 0.3% year-over-year, with EPS remaining unchanged at $0.76 [1] - The revenue fell short of the Zacks Consensus Estimate of $833.46 million, resulting in a surprise of -0.82%, while the EPS exceeded the consensus estimate of $0.75 by 1.33% [1] Financial Performance Metrics - Specialty Engineered Materials sales were $308.40 million, below the average estimate of $312.56 million, reflecting a year-over-year decline of 1.9% [4] - Color, Additives and Inks sales reached $519.70 million, slightly below the average estimate of $521.10 million, with a year-over-year increase of 0.9% [4] - Corporate sales reported a loss of -$1.50 million, worse than the average estimate of -$0.80 million, marking a significant year-over-year change of +114.3% [4] Operating Income Analysis - Operating income for Color, Additives and Inks was $78.60 million, slightly above the average estimate of $78.01 million [4] - Operating income for Specialty Engineered Materials was $47.10 million, below the average estimate of $49.71 million [4] - Corporate operating loss was -$125 million, significantly worse than the average estimate of -$32.27 million [4] Stock Performance - Avient's shares have returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]